Pacific Biosciences of California Inc (STU:P09)
€ 1.4505 -0.0070 (-0.48%) Market Cap: 458.21 Mil Enterprise Value: 833.54 Mil PE Ratio: 0 PB Ratio: 209.38 GF Score: 57/100

Q1 2025 Pacific Biosciences of California Inc Earnings Call Transcript

May 08, 2025 / 08:30PM GMT
Release Date Price: €1.05 (+8.11%)
Operator

Good afternoon, everyone, and welcome to the PacBio first quarter-2025 earnings conference call. (Operator Instructions) There's also not event is being recorded.

At this time, I'd like to turn the floor over to Todd Friedman, Investor Relations. Sir, please go ahead.

Todd Friedman
Pacific Biosciences of California Inc - Senior Director of Investor Relations

Good afternoon and welcome to PacBio's first-quarter 2025 earnings conference call.

Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call. A copy of which is available on the Investors section of our website at www.pacb.com or is furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. A copy of our earnings presentation is also available on the investors Section of our website.

With me today are Christian Henry, President and Chief Executive Officer; and Jim

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot